111. Congenital myopathy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 17 - (DrugBank : 5) / Drug target gene : 1 - Drug target pathways : 9
Congenital myopathy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 111 | Congenital myopathy |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 6 | Parkinson disease |
| 299 | Cystic fibrosis |
| 2 | Amyotrophic lateral sclerosis |
| 231 | Alpha-1-antitrypsin deficiency |
| 17 | Multiple system atrophy |
| 46 | Malignant rheumatoid arthritis |
| 49 | Systemic lupus erythematosus |
| 85 | Idiopathic interstitial pneumonia |
| 86 | Pulmonary arterial hypertension |
| 89 | Lymphangioleiomyomatosis |
| 96 | Crohn disease |
| 157 | Sturge-Weber syndrome |
| 158 | Tuberous sclerosis |
| 256 | Muscle glycogenosis |
| 278 | Huge lymphatic malformation with cervicofacial lesion |
| 228 | Bronchiolitis obliterans |
| 5 | Progressive supranuclear palsy |
| 113 | Muscular dystrophy |
| 227 | Osler disease |
| 296 | Biliary atresia |
| 11 | Myasthenia gravis |
| 22 | Moyamoya disease |
| 70 | Spinal stenosis |
| 167 | Marfan syndrome |
| 57 | Idiopathic dilated cardiomyopathy |
| 210 | Single Ventricle |
| 215 | Tetralogy of Fallot |
| 1 | Spinal and bulbar muscular atrophy |
| 118 | Myelomeningocele |
| 169 | Menkes disease |
| 170 | Occipital horn syndrome |
| 3 | Spinal muscular atrophy |
| 12 | Congenital myasthenic syndrome |